Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from SS Innovations International ( (SSII) ).
On May 5, 2025, SS Innovations International reiterated its guidance for the first quarter of 2025 and provided insights into the second quarter order trends. The company reported that 14 SSi Mantra surgical robotic systems were installed in the first quarter, bringing the total to 78 systems by March 31, 2025. Revenue for the quarter is expected to be approximately $6.4 million with a gross margin of 45%. By April 30, 2025, 80 systems were installed in 75 hospitals, with over 3,800 surgeries performed using the SSi Mantra, including over 200 robotic cardiac surgeries. The company noted a significant increase in orders for April 2025, with a total of 9 orders, marking a 200% rise from the previous year.
More about SS Innovations International
SS Innovations International, Inc. (Nasdaq: SSII) is a company focused on developing innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. Their primary products include the ‘SSi Mantra’ surgical robotic system and ‘SSi Mudra’ surgical instruments, which support various surgical procedures, including robotic cardiac surgery. The company is headquartered in India and plans to expand its global presence with its advanced, user-friendly, and cost-effective solutions.
YTD Price Performance: 34.74%
Average Trading Volume: 20,474
Technical Sentiment Signal: Sell
Current Market Cap: $2.03B
Learn more about SSII stock on TipRanks’ Stock Analysis page.